[{"id":"6d824741-8753-4959-8949-c14b740d29dc","acronym":"MORAb-009-006","url":"https://clinicaltrials.gov/study/NCT01521325","created_at":"2021-01-18T06:24:00.019Z","updated_at":"2024-07-02T16:37:28.752Z","phase":"Phase 1","brief_title":"A Single-Dose Pilot Study of Radiolabeled Amatuximab (MORAb-009) in Mesothelin Over Expressing Cancers","source_id_and_acronym":"NCT01521325 - MORAb-009-006","lead_sponsor":"Morphotek","biomarkers":" MSLN","pipe":" | ","alterations":" MSLN expression","tags":["MSLN"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e MSLN expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e amatuximab (MORAb-009)"],"overall_status":"Completed","enrollment":" Enrollment 6","initiation":"Initiation: 09/01/2011","start_date":" 09/01/2011","primary_txt":" Primary completion: 03/01/2013","primary_completion_date":" 03/01/2013","study_txt":" Completion: 03/01/2013","study_completion_date":" 03/01/2013","last_update_posted":"2016-09-30"}]